David Tong

9.7k total citations · 1 hit paper
98 papers, 6.1k citations indexed

About

David Tong is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Tong has authored 98 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 23 papers in Pulmonary and Respiratory Medicine and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Tong's work include Acute Ischemic Stroke Management (35 papers), Cerebrovascular and Carotid Artery Diseases (13 papers) and Breast Cancer Treatment Studies (13 papers). David Tong is often cited by papers focused on Acute Ischemic Stroke Management (35 papers), Cerebrovascular and Carotid Artery Diseases (13 papers) and Breast Cancer Treatment Studies (13 papers). David Tong collaborates with scholars based in United States, United Kingdom and Australia. David Tong's co-authors include Gregory W. Albers, Michael E. Moseley, Michael P. Marks, Maarten G. Lansberg, Christian Beaulieu, Midori A. Yenari, Alexander Norbash, P. Winter, Michael W. O’Brien and R.D. Rubens and has published in prestigious journals such as The Lancet, Circulation and Annals of Internal Medicine.

In The Last Decade

David Tong

93 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infective Endocarditis

2005 1.2k citations Larry M. Baddour, Walter R. Wilson et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Tong United States	39	3.2k	1.5k	1.1k	1.0k	868	98	6.1k
Gianfranco Ferraccioli Italy	59	1.3k 0.4×	1.2k 0.8×	400 0.4×	1.0k 1.0×	1.1k 1.3×	370	11.5k
David H. Neustadt United States	15	1.0k 0.3×	949 0.6×	412 0.4×	2.4k 2.3×	1.4k 1.6×	35	17.5k
Louis A. Healey United States	12	1.1k 0.3×	1.3k 0.9×	406 0.4×	2.5k 2.4×	1.3k 1.5×	15	17.8k
Chia‐Jen Liu Taiwan	52	1.1k 0.4×	778 0.5×	271 0.2×	359 0.4×	1.2k 1.4×	212	8.2k
Yeong Wook Song South Korea	46	1.4k 0.4×	720 0.5×	300 0.3×	362 0.4×	860 1.0×	309	8.3k
Christopher C. Silliman United States	61	1.7k 0.5×	1.6k 1.1×	673 0.6×	150 0.1×	1.8k 2.1×	311	13.5k
Bernhard Maisch Germany	54	2.5k 0.8×	1.2k 0.8×	833 0.8×	1.4k 1.3×	2.9k 3.4×	461	15.6k
Solbritt Rantapää‐Dahlqvist Sweden	61	911 0.3×	958 0.7×	199 0.2×	2.3k 2.2×	710 0.8×	248	12.6k
Kentaro Tanaka Japan	42	803 0.3×	1.6k 1.1×	333 0.3×	460 0.5×	872 1.0×	307	6.7k
Hiroshi Yamamoto Japan	38	797 0.2×	1.4k 0.9×	556 0.5×	468 0.5×	1.1k 1.3×	230	5.5k

Countries citing papers authored by David Tong

Since Specialization

Citations

This map shows the geographic impact of David Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tong more than expected).

Fields of papers citing papers by David Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tong. The network helps show where David Tong may publish in the future.

Co-authorship network of co-authors of David Tong

This figure shows the co-authorship network connecting the top 25 collaborators of David Tong. A scholar is included among the top collaborators of David Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tong. David Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dawson, L., Stephen Quinn, David Tong, et al.. (2022). Colchicine and Quality of Life in Patients With Acute Coronary Syndromes: Results From the COPS Randomized Trial. Cardiovascular revascularization medicine. 44. 53–59. 2 indexed citations

Tong, David, et al.. (2019). Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients. Heart Lung and Circulation. 29(3). 414–421. 71 indexed citations

Tong, David, Robert Whitbourn, Andrew I. MacIsaac, et al.. (2018). High-Sensitivity C-Reactive Protein Is a Predictor of Coronary Microvascular Dysfunction in Patients with Ischemic Heart Disease. Frontiers in Cardiovascular Medicine. 4. 81–81. 22 indexed citations

Beare, Richard, Thanh G. Phan, Velandai Srikanth, et al.. (2018). Staff Recall Travel Time for ST Elevation Myocardial Infarction Impacted by Traffic Congestion and Distance: A Digitally Integrated Map Software Study. Frontiers in Cardiovascular Medicine. 4. 89–89. 2 indexed citations

Tong, David, et al.. (2017). In‐hospital ‘CODE STEMI’ improves door‐to‐balloon time in patients undergoing primary percutaneous coronary intervention. Emergency Medicine Australasia. 30(2). 222–227. 9 indexed citations

Barazangi, Nobl, Xiaomeng Chen, David Grosvenor, et al.. (2016). Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study. Journal of Stroke and Cerebrovascular Diseases. 25(5). 1110–1118. 5 indexed citations

Barazangi, Nobl, et al.. (2013). Use of SMART IV Thrombolysis Criteria at Community Hospitals Is Safe (P04.074). Neurology. 80(7_supplement). 1 indexed citations

Spokoyny, Ilana, et al.. (2013). Reduced Clopidogrel Metabolism in a Multiethnic Population: Prevalence and Rates of Recurrent Cerebrovascular Events. Journal of Stroke and Cerebrovascular Diseases. 23(4). 694–698. 22 indexed citations

Blankenberg, Francis G., Liping Liu, Maya A. Koike, et al.. (2006). 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody. European Journal of Nuclear Medicine and Molecular Imaging. 33(5). 566–574. 44 indexed citations

10.

Baddour, Larry M., Walter R. Wilson, Arnold S. Bayer, et al.. (2005). Infective Endocarditis. Circulation. 111(23). e394–434. 1204 indexed citations breakdown →

11.

Fentiman, Ian S., et al.. (2004). Caesium(137) implant as sole radiation therapy for operable breast cancer. British journal of surgery. 91. 116–116. 6 indexed citations

12.

Adami, Alessandro, Vincent Thijs, David Tong, et al.. (2002). Use of diffusion weighted MRI to predict the occurrence and severity of hemorrhagic transformation in a rabbit model of embolic stroke. Brain Research. 944(1-2). 32–39. 16 indexed citations

13.

Tong, David. (2002). Intravenous rt-PA for Stroke. Current Medical Research and Opinion. 18(sup2). s35–s43. 2 indexed citations

14.

Tong, David & David Grosvenor. (2000). Regional and Racial Variations in the Use of Thrombolytic Therapy for Acute Stroke at US Academic Medical Centers: The UHC Stroke Benchmarking Project. Stroke. 32. 375–375. 1 indexed citations

15.

Tong, David & Gregory W. Albers. (2000). Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: potential use in guiding thrombolytic therapy. Current Opinion in Neurology. 13(1). 45–50. 30 indexed citations

16.

Adami, Alessandro, et al.. (2000). INITIAL ADC PREDICTS THE OCCURRENCE AND SEVERITY OF HEMORRHAGIC TRANSFORMATION IN EXPERIMENTAL STROKE. Stroke. 32. 350–350. 2 indexed citations

17.

Chaudary, M.A., David Tong, Rosemary R. Millis, et al.. (1997). Loco-regional recurrence following mastectomy for early breast carcinoma: efficacy of radiotherapy at the time of recurrence. European Journal of Surgical Oncology. 23(4). 348–353. 11 indexed citations

18.

Fentiman, Ian S., Christopher Poole, David Tong, et al.. (1996). Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. European Journal of Cancer. 32(4). 608–611. 128 indexed citations

19.

Fentiman, Ian S., M.A. Chaudary, P. Winter, et al.. (1989). Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer. Breast Cancer Research and Treatment. 13(3). 237–241. 18 indexed citations

20.

Rubens, RD, et al.. (1988). Prednisolone improves the response to primary endocrine treatment for advanced breast cancer. British Journal of Cancer. 58(5). 626–630. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact